Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2018 | 04-2018 | 01-2018 | 10-2017 | 07-2017 | |
| Sales | 6,225 | 4,923 | 5,082 | 5,203 | 5,033 |
| Cost of Goods | 3,083 | 2,785 | 2,473 | 2,653 | 2,642 |
| Gross Profit | 3,142 | 2,138 | 2,609 | 2,550 | 2,391 |
| Operating Expenses | 2,744 | 3,521 | 3,149 | 3,273 | 3,652 |
| Operating Income | 481 | -598 | -67 | -70 | -619 |
| Other Income | 1 | -18 | -7 | -13 | -51 |
| Pre-tax Income | 482 | -616 | -74 | -83 | -670 |
| Income Tax | N/A | 16 | 2 | 11 | 4 |
| Net Income Continuous | 482 | -632 | -76 | -94 | -674 |
| Net Income | $482 | $-632 | $-76 | $-94 | $-674 |
| EPS Basic Total Ops | 0.04 | -0.05 | -0.01 | -0.01 | -0.06 |
| EPS Basic Continuous Ops | 0.04 | -0.06 | -0.01 | -0.01 | -0.06 |
| EPS Diluted Total Ops | 0.04 | -0.05 | -0.01 | -0.01 | -0.06 |
| EPS Diluted Continuous Ops | 0.04 | -0.06 | -0.01 | -0.01 | -0.06 |
| EBITDA(a) | $599 | $-491 | $54 | $20 | $-577 |